1. Home
  2. TYRA vs CLMB Comparison

TYRA vs CLMB Comparison

Compare TYRA & CLMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TYRA
  • CLMB
  • Stock Information
  • Founded
  • TYRA 2018
  • CLMB 1982
  • Country
  • TYRA United States
  • CLMB United States
  • Employees
  • TYRA N/A
  • CLMB N/A
  • Industry
  • TYRA Biotechnology: Pharmaceutical Preparations
  • CLMB Retail: Computer Software & Peripheral Equipment
  • Sector
  • TYRA Health Care
  • CLMB Technology
  • Exchange
  • TYRA Nasdaq
  • CLMB Nasdaq
  • Market Cap
  • TYRA 556.4M
  • CLMB 489.1M
  • IPO Year
  • TYRA 2021
  • CLMB N/A
  • Fundamental
  • Price
  • TYRA $10.09
  • CLMB $107.31
  • Analyst Decision
  • TYRA Strong Buy
  • CLMB Buy
  • Analyst Count
  • TYRA 6
  • CLMB 1
  • Target Price
  • TYRA $30.50
  • CLMB $136.00
  • AVG Volume (30 Days)
  • TYRA 281.8K
  • CLMB 32.9K
  • Earning Date
  • TYRA 05-08-2025
  • CLMB 04-30-2025
  • Dividend Yield
  • TYRA N/A
  • CLMB 0.63%
  • EPS Growth
  • TYRA N/A
  • CLMB 65.26
  • EPS
  • TYRA N/A
  • CLMB 4.26
  • Revenue
  • TYRA N/A
  • CLMB $511,229,000.00
  • Revenue This Year
  • TYRA N/A
  • CLMB $7.10
  • Revenue Next Year
  • TYRA N/A
  • CLMB $8.00
  • P/E Ratio
  • TYRA N/A
  • CLMB $24.70
  • Revenue Growth
  • TYRA N/A
  • CLMB 42.25
  • 52 Week Low
  • TYRA $6.42
  • CLMB $49.70
  • 52 Week High
  • TYRA $29.60
  • CLMB $145.00
  • Technical
  • Relative Strength Index (RSI)
  • TYRA 52.97
  • CLMB 51.24
  • Support Level
  • TYRA $8.80
  • CLMB $94.98
  • Resistance Level
  • TYRA $10.56
  • CLMB $108.48
  • Average True Range (ATR)
  • TYRA 0.75
  • CLMB 4.85
  • MACD
  • TYRA 0.06
  • CLMB 0.54
  • Stochastic Oscillator
  • TYRA 58.90
  • CLMB 81.87

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About CLMB Climb Global Solutions Inc.

Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.

Share on Social Networks: